Serial 85526982
Live / Registered — Registered and renewed (as of 05 Apr 2024)
What this means for you
Registered since 03 Dec 2013. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 03 Dec 2023).
Record
- Serial number
- 85526982
- Registration number
- 4444435
- Mark type
- Design / logo
- Filed
- 27 Jan 2012
- Published for opposition
- 19 Jun 2012
- Registered
- 03 Dec 2013
- Next maintenance due
- 03 Dec 2023
- Attorney of record
- Lynn E. Rzonca
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of gastro-intestinal disorders, cholera, diarrhea, irritable bowel syndrome, symptoms caused by AIDS/HIV
Owner
- Napo Pharmaceuticals, Inc., San Francisco, CA, US
- Napo Pharmaceuticals, Inc., San Francisco, CA, US
- Napo Pharmaceuticals, Inc., San Francisco, CA, US
Prosecution history
- 05 Apr 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 05 Apr 2024 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 05 Apr 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 05 Apr 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Nov 2023 — TEAS SECTION 8 & 9 RECEIVED
- 03 Dec 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 26 Nov 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Nov 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Nov 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Apr 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 18 Apr 2019 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 17 Apr 2019 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 12 Apr 2019 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 12 Apr 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Mar 2019 — TEAS SECTION 8 & 15 RECEIVED